Fortis Healthcare Q2 FY25 PAT up 5% at Rs. 193 Cr
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Hospital business revenues increase 13.9% to Rs. 1,655 crore
The centre is equipped with the most modern tools and provides an environment soothing for all professionals and patients
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
The company uses iPS cells to develop treatments for diseases relating to the kidney
ISB 2001 demonstrated a favorable safety and tolerability profile, and an overall response rate (ORR) of 75% in r/r MM
Revenue share from the North America increased to 79% in Q2 FY25 as compared to 67% in Q2 FY24
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Subscribe To Our Newsletter & Stay Updated